Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition for enhancing radiotherapy comprising fusion protein containing IL-2 protein and CD80 protein

Pharmaceutical composition for enhancing radiotherapy comprising fusion protein containing IL-2 protein and CD80 protein

US Patent 12478675 · Granted Nov 25, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lactobacillus fermentum strain, and composition for preventing or treating metab2025
Lactobacillus helveticus strain and composition containing same for prevention o2025
Fusion protein comprising anti-CD73 antibody and IL-2, and use thereof2025
Fusion protein comprising anti-CD73 antibody and IL-2, and use thereof2025
Extracellular domain of alpha subunit of IgE Fc receptor, pharmaceutical composi2025
Composition comprising three Lactobacillus sp. strains, and use thereof2025
Fusion protein comprising IL-2 protein and CD80 protein, and use thereof2025
Fusion protein comprising IL-2 protein and CD80 protein, and use thereof2025
Pharmaceutical composition for cancer treatment comprising fusion protein includ2024
Pharmaceutical composition for cancer treatment comprising fusion protein includ2024
Pharmaceutical composition for cancer treatment comprising fusion protein includ2024
Pharmaceutical composition for treatment of cancer, comprising an immune checkpo2023